Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;51(7):715.
doi: 10.1016/j.arcmed.2020.07.002. Epub 2020 Jul 20.

Response to: Amantadine, COVID-19 and Parkinsonism

Gonzalo Emiliano Aranda-Abreu  1
Affiliations
Comment

Response to: Amantadine, COVID-19 and Parkinsonism

Gonzalo Emiliano Aranda-Abreu. Arch Med Res. 2020 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • Amantadine, COVID-19 and Parkinsonism.
    Wiwanitkit V. Wiwanitkit V. Arch Med Res. 2020 Oct;51(7):714. doi: 10.1016/j.arcmed.2020.07.001. Epub 2020 Jul 3. Arch Med Res. 2020. PMID: 32660794 Free PMC article. No abstract available.

References

    1. Kobylecki C., Jones T., Lim C.K. Phenomenology and outcomes of in-patients with Parkinson’s disease during COVID-19 pandemic. [letter] Mov Disord. 2020 doi: 10.1002/mds.28205. Online ahead of print. - DOI - PMC - PubMed
    1. Cilia R., Bonvegna S., Straccia G. Effects of COVID-19 on Parkinson’s Disease Clinical Features: A Community-Based Case-Control Study. Mov Disord. 2020 doi: 10.1002/mds.28170. Online ahead of print. - DOI - PMC - PubMed
    1. Aranda Abreu G.E., Hernández Aguilar M.E., Herrera Covarrubias D. Amantadine as a drug to mitigate the effects of COVID-19. Med Hypotheses. 2020;140:109755. - PMC - PubMed
    1. Araújo R., Aranda-Martínez J.D., Aranda-Abreu G.E. Amantadine Treatment for People with COVID-19. Arch Med Res. 2020 doi: 10.1016/j.arcmed.2020.06.009. Online ahead of print. - DOI - PMC - PubMed
    1. Aranda-Abreu G.E., Aranda-Martínez J.D., Araújo R. Use of amantadine in a patient with SARS-CoV-2. [letter] J Med Virol. 2020 doi: 10.1002/jmv.26179. Online ahead of print. - DOI - PMC - PubMed